Patents by Inventor Guodong Liu

Guodong Liu has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11931350
    Abstract: This application describes compounds that can act as opioid receptor ligands, which compounds can be used in the treatment of, for example, pain and pain related disorders.
    Type: Grant
    Filed: July 2, 2021
    Date of Patent: March 19, 2024
    Assignee: TREVENA, INC.
    Inventors: Dennis Yamashita, Dimitar Gotchev, Philip Pitis, Xiao-Tao Chen, Guodong Liu, Catherine C. K. Yuan
  • Publication number: 20240087492
    Abstract: A display substrate, a test method for the display substrate and a display device are provided. The display substrate includes a base substrate, a touch detection circuit layer and a pixel driving circuit layer. The display substrate includes a display region and a non-display region surrounding the display region. The touch detection circuit layer includes a driving signal line and a dummy electrode line arranged side by side in the display region and insulated from each other, and both the driving signal line and the dummy electrode line extend from the display region to the non-display region. The non-display region is provided with a plurality of test pads including a first pad electrically connected to the driving signal line and a second pad electrically connected to the dummy electrode line.
    Type: Application
    Filed: September 28, 2022
    Publication date: March 14, 2024
    Applicants: HEFEI XINSHENG OPTOELECTRONICS TECHNOLOGY CO., LTD., BOE TECHNOLOGY GROUP CO., LTD.
    Inventors: Guodong Liu, Peng Wu, Jideng Zhou, Yong Qian
  • Patent number: 11912713
    Abstract: The present embodiments are directed, in part, to compounds, or pharmaceutically acceptable salts thereof, or pharmaceutical compositions thereof for modulating the activity of delta opioid receptor, biased and/or unbiased, and/or methods for treating pain, migraines, headaches, depression, Parkinsons Disease, anxiety, and/or overactive bladder, and other disorders and conditions described herein or any combination thereof.
    Type: Grant
    Filed: November 22, 2021
    Date of Patent: February 27, 2024
    Assignee: Trevena, Inc.
    Inventors: Aimee Crombie Speerschneider, Dennis Shinji Yamashita, Philip Michael Pitis, Michael John Hawkins, Guodong Liu, Tamara Ann Miskowski Daubert, Catherine C. K. Yuan, Robert Borbo Kargbo, Robert Jason Herr, Donna Romero
  • Patent number: 11912693
    Abstract: The present embodiments are directed, in part, to compounds, or pharmaceutically acceptable salts thereof, or pharmaceutical compositions thereof for modulating the activity of S1P1 receptor and methods of using the same.
    Type: Grant
    Filed: June 12, 2018
    Date of Patent: February 27, 2024
    Assignee: TREVENA, INC.
    Inventors: Philip Michael Pitis, Robert Eugene Boyd, Tamara Ann Miskowski Daubert, Michael John Hawkins, Guodong Liu, Aimee Crombie Speerschneider
  • Publication number: 20240001438
    Abstract: Disclosed is an amorphous nanocrystalline alloy strip. When the amorphous nanocrystalline alloy strip is cut into a plurality of narrow strips having a same width of less than or equal to 10 mm, a relative length difference among the plurality of narrow strips is not greater than 0.50%. Further disclosed is a method for manufacturing the amorphous nanocrystalline alloy strip. The amorphous nanocrystalline alloy strip has good surface flatness. The transverse temperature non-uniformity of molten steel inside a melting pool and the surface temperature non-uniformity of a cooling roller within a strip manufacturing position range are controlled in a process of manufacturing the amorphous nanocrystalline alloy strip, so that the surface flatness of the manufactured strip is improved. The manufacturing process is simple and convenient.
    Type: Application
    Filed: March 16, 2021
    Publication date: January 4, 2024
    Inventors: Wenzhi CHEN, Guodong LIU, Baisong LI, Yang SHI, Zhigang LI
  • Publication number: 20230303531
    Abstract: The present embodiments are directed, in part, to compounds, or pharmaceutically acceptable salts thereof, or pharmaceutical compositions thereof for modulating the activity of delta opioid receptor, biased and/or unbiased, and/or methods for treating pain, migraines, headaches, depression, Parkinsons Disease, anxiety, and/or overactive bladder, and other disorders and conditions described herein or any combination thereof.
    Type: Application
    Filed: May 10, 2023
    Publication date: September 28, 2023
    Inventors: Aimee Crombie Speerschneider, Dennis Shinji Yamashita, Philip Michael Pitis, Michael John Hawkins, Guodong Liu, Tamara Ann Miskowski Daubert, Catherine C.K. Yuan, Robert Borbo Kargbo, Robert Jason Herr, Donna Romero
  • Patent number: 11760687
    Abstract: An alkali-free ultrafine glass fiber formula includes the following components, in mass percentage calculated based on 100 Kg: SiO2: 50% to 65%, Al2O3: 10% to 16.5%, CaO: 17% to 28%, MgO: 0.2% to 4.0%, Na2O and K2O: 0.1% to 0.8% in total, CeO2: 0.1% to 0.5%, Li2O: 0.1% to 0.7%, Fe2O3: 0.05% to 0.6%, TiO2: 0.1% to 1%, and impurities: the balance. In the preparation of alkali-free ultrafine glass fibers, no fluorine and boron-containing raw materials are used, and CeO2 and Li2O are introduced, which avoids the use of B2O3 and F that have a large impact on the environment, and reduces environmental pollution. A single fiber strength of prepared glass fibers is about 9% higher than that of the traditional E glass fibers, and the comprehensive performance of a prepared glass fiber product is significantly superior than that of the existing E glass fiber product.
    Type: Grant
    Filed: December 29, 2020
    Date of Patent: September 19, 2023
    Assignee: TAISHAN FIBERGLASS ZOUCHENG CO., LTD.
    Inventors: Yundong Sun, Wei Li, Degang Zhang, Guo Zhang, Qiang Fang, Yongyan Li, Cong Ding, Guodong Liu, Caihua Liu
  • Publication number: 20230291357
    Abstract: Embodiments of the present application provide a method for predicting envelope features. The method includes: according to baseband data or data after modulation mapping, a peak value of a radio frequency envelope signal, a time point corresponding to the peak value, a valley point of the radio frequency envelope signal and a time point corresponding to the valley point are predicted; according to the valley point and the time point corresponding thereto, a generated reference value is sent to a low-bandwidth control signal generating module to obtain a control signal; according to adjacent valley point and peak point, and time points corresponding thereto, generated status information is sent to a high-bandwidth control signal generating module to obtain a control switch signal; and when in an ascending status, according to a key information string, a slope k of a connecting line is determined, and a corresponding filter inductor is turned on.
    Type: Application
    Filed: May 22, 2023
    Publication date: September 14, 2023
    Applicant: Nanjing University Of Posts And Telecommunications
    Inventors: Yan ZHOU, Guodong LIU, Wenxuan XIE, Yan FAN, Zhihao ZHANG
  • Publication number: 20230234946
    Abstract: The present embodiments are directed, in part, to compounds, or pharmaceutically acceptable salts thereof, or pharmaceutical compositions thereof for modulating the activity of S1P1 receptor and methods of using the same.
    Type: Application
    Filed: April 5, 2023
    Publication date: July 27, 2023
    Inventors: Philip Michael Pitis, Robert Eugene Boyd, Tamara Ann Miskowski Daubert, Michael John Hawkins, Guodong Liu, Aimee Crombie Speerschneider
  • Patent number: 11702408
    Abstract: The present embodiments are directed, in part, to 5-membered aza-heterocyclic containing delta-opioid receptor modulating compounds, such as those of Formula I, or pharmaceutically acceptable salts thereof, or pharmaceutical compositions thereof for modulating the activity of delta opioid receptor, biased and/or unbiased, and/or methods for treating pain, migraines, headaches, depression, Parkinson's Disease, anxiety, and/or overactive bladder, and other disorders and conditions described herein or any combination thereof.
    Type: Grant
    Filed: February 15, 2018
    Date of Patent: July 18, 2023
    Assignee: TREVENA, INC.
    Inventors: Aimee Crombie Speerschneider, Dennis Shinji Yamashita, Philip Michael Pitis, Michael John Hawkins, Guodong Liu, Tamara Ann Miskowski Daubert, Catherine C. K. Yuan, Robert Borbo Kargbo, Robert Jason Herr, Donna Romero
  • Publication number: 20230224228
    Abstract: A controller groups a plurality of service application types into a plurality of application type groups based on link quality requirements of the plurality of service application types in a network; determines sending priorities based on the plurality of application type groups; separately determines at least one link for the plurality of application type groups based on link quality requirements of the plurality of application type groups and link quality information of a plurality of links in the network; separately determines network configurations for the plurality of application type groups based on the at least one link separately determined for the plurality of application type groups, the sending priorities of the plurality of application type groups, the link quality requirements of the plurality of application type groups, and a policy recommendation engine; and delivers the network configurations to a policy execution point device.
    Type: Application
    Filed: March 17, 2023
    Publication date: July 13, 2023
    Inventors: Bayaer Dahu, Guodong Liu, Jikun Ding
  • Publication number: 20230203002
    Abstract: The present embodiments are directed, in part, to compounds, or pharmaceutically acceptable salts thereof, or pharmaceutical compositions thereof for modulating the activity of delta opioid receptor, biased and/or unbiased, and/or methods for treating pain, migraines, headaches, depression, Parkinsons Disease, anxiety, and/or overactive bladder, and other disorders and conditions described herein or any combination thereof.
    Type: Application
    Filed: August 3, 2022
    Publication date: June 29, 2023
    Inventors: Aimee Crombie Speerschneider, Dennis Shinji Yamashita, Philip Michael Pitis, Michael John Hawkins, Guodong Liu, Tamara Ann Miskowski Daubert, Catherine C.K. Yuan, Robert Borbo Kargbo, Robert Jason Herr, Donna Romero, Gregory J. Pacofsky
  • Patent number: 11515377
    Abstract: Disclosed herein is a display panel, comprising: a support; a first layer comprising a light emitter, a first region and a second region; a second layer sandwiched between the first layer and the support; wherein the first region and the second region allow light scattered by an object (e.g., a person's finger) to transmit therethrough; wherein the second layer allows light transmitted through the first region to reach the support and comprises a light-blocking layer configured to attenuate light transmitted through the second region.
    Type: Grant
    Filed: January 24, 2019
    Date of Patent: November 29, 2022
    Assignees: Chengdu BOE Optoelectronics Technology Co., Ltd., BEIJING BOE TECHNOLOGY DEVELOPMENT CO., LTD.
    Inventors: Kuo Sun, Hai Zheng, Jianxiong Huang, Guodong Liu
  • Publication number: 20220348588
    Abstract: The present embodiments are directed, in part, to compounds, or pharmaceutically acceptable salts thereof, or pharmaceutical compositions thereof for modulating the activity of delta opioid receptor, biased and/or unbiased, and/or methods for treating pain, migraines, headaches, depression, Parkinsons Disease, anxiety, and/or overactive bladder, and other disorders and conditions described herein or any combination thereof.
    Type: Application
    Filed: November 22, 2021
    Publication date: November 3, 2022
    Inventors: Aimee CROMBIE SPEERSCHNEIDER, Dennis SHINJI YAMASHITA, Philip Michael PITIS, Michael John HAWKINS, Guodong Liu, Tamara Ann MISKOWSKI DAUBERT, Catherine C.K. YUAN, Robert BORBO KARGBO, Robert Jason HERR, Donna ROMERO
  • Publication number: 20220353232
    Abstract: Example data transmission methods and apparatus are described. In one example method, a data distribution point obtains a first correspondence between a first virtual extensible local area network identifier (VXLAN ID) and an address of a first terminal. The data distribution point receives a first VXLAN packet based on a tunnel of a first VXLAN, where the first VXLAN packet includes the first VXLAN ID and first data. The address of the first terminal is determined based on the first VXLAN ID carried in the first VXLAN packet and the first correspondence. The first distribution point sends the first data to the first terminal based on the address of the first terminal.
    Type: Application
    Filed: July 13, 2022
    Publication date: November 3, 2022
    Inventors: Bayaer DAHU, Guodong LIU, Yuanbin YIN
  • Publication number: 20220344619
    Abstract: The present disclosure provides a display panel and a manufacture method thereof. The display panel has a through hole penetrating the display panel wherein the display panel further has a water and oxygen insulation structure having: a substrate; a plurality of ring-shaped insulation walls; and a light emitting layer; wherein in a direction outwards from a center of the through hole, at least one side of at least one of the plurality of ring-shaped insulation walls has an undercut, such that the light emitting layer is discontinuous at the undercut, and opposite sides of any two adjacent ones of the plurality of ring-shaped insulation walls do not both have an undercut.
    Type: Application
    Filed: April 8, 2021
    Publication date: October 27, 2022
    Applicants: Chengdu BOE Optoelectronics Technology Co., Ltd., BOE Technology Group Co., Ltd.
    Inventors: Wuyang Zhao, Xiaoliang Guo, Liang Song, Guodong Liu, Zhongfei Dong
  • Patent number: 11465980
    Abstract: The present embodiments are directed, in part, to compounds, or pharmaceutically acceptable salts thereof, or pharmaceutical compositions thereof for modulating the activity of delta opioid receptor, biased and/or unbiased, and/or methods for treating pain, migraines, headaches, depression, Parkinsons Disease, anxiety, and/or overactive bladder, and other disorders and conditions described herein or any combination thereof.
    Type: Grant
    Filed: February 27, 2019
    Date of Patent: October 11, 2022
    Assignee: TREVENA, INC.
    Inventors: Aimee Crombie Speerschneider, Dennis Shinji Yamashita, Philip Michael Pitis, Michael John Hawkins, Guodong Liu, Tamara Ann Miskowski Daubert, Catherine C. K. Yuan, Robert Borbo Kargbo, Robert Jason Herr, Donna Romero, Gregory J. Pacofsky
  • Patent number: 11410586
    Abstract: A display device and driving method thereof and a manufacturing method of a display substrate involve an array substrate and manufacturing method thereof. The array substrate includes: a base substrate; and a number of display sub-pixels arranged in a matrix on the base substrate. Each individual display sub-pixel includes: a pixel electrode; a first common electrode; and a second common electrode; wherein the first common electrode and the second common electrode are insulated from each other; and wherein the pixel electrode is configured to interact respectively with the first common electrode and the second common electrode so as to conduct one or more display operations.
    Type: Grant
    Filed: March 19, 2019
    Date of Patent: August 9, 2022
    Assignees: HEFEI XINSHENG OPTOELECTRONICS TECHNOLOGY CO., LTD., BOE TECHNOLOGY GROUP CO., LTD.
    Inventors: Donghui Zhang, Xiaoye Ma, Guodong Liu, Xiaofang Gu, Ruifang Du, Huan Ni, Zhenyu Han
  • Publication number: 20220175747
    Abstract: This application describes compounds that can act as opioid receptor ligands, which compounds can be used in the treatment of, for example, pain and pain related disorders.
    Type: Application
    Filed: July 2, 2021
    Publication date: June 9, 2022
    Inventors: Dennis Yamashita, Dimitar Gotchev, Philip Pitis, Xiao-Tao Chen, Guodong Liu, Catherine C.K. Yuan
  • Publication number: 20220169562
    Abstract: An alkali-free ultrafine glass fiber formula includes the following components, in mass percentage calculated based on 100 Kg: SiO2: 50% to 65%, Al2O3: 10% to 16.5%, CaO: 17% to 28%, MgO: 0.2% to 4.0%, Na2O and K2O: 0.1% to 0.8% in total, CeO2: 0.1% to 0.5%, Li2O: 0.1% to 0.7%, Fe2O3: 0.05% to 0.6%, TiO2: 0.1% to 1%, and impurities: the balance. In the preparation of alkali-free ultrafine glass fibers, no fluorine and boron-containing raw materials are used, and CeO2 and Li2O are introduced, which avoids the use of B2O3 and F that have a large impact on the environment, and reduces environmental pollution. A single fiber strength of prepared glass fibers is about 9% higher than that of the traditional E glass fibers, and the comprehensive performance of a prepared glass fiber product is significantly superior than that of the existing E glass fiber product.
    Type: Application
    Filed: December 29, 2020
    Publication date: June 2, 2022
    Applicant: TAISHAN FIBERGLASS ZOUCHENG CO., LTD.
    Inventors: Yundong SUN, Wei LI, Degang ZHANG, Guo ZHANG, Qiang FANG, Yongyan LI, Cong DING, Guodong LIU, Caihua LIU